study on clopidogrel in inhibition of platelet aggregation in suspected angina patients, treated with a daily dose of  75 mg of clopidogrel for 7 days

How to Cite:Khan H, Jan H, Hafizullah M. study on clopidogrel in inhibition of platelet aggregation in suspected angina patients, treated with a daily dose of 75 mg of clopidogrel for 7 days. Iran J Pharm Res. 2022;8(2):e128628. doi: https://doi.org/10.22037/ijpr.2010.801

Abstract

This study was performed to assess the clopidogrel activity in inhibition of platelet aggregation in suspected angina patients on a daily dosag of 75 mg of clopidogrel for at least 7 days.

This clinical trial was conducted in the outpatients department of Cardiology, Post graduate Medical Institute, Lady Reading Hospital, Peshawar from 15^th October 2007 to 20^th December 2007. We included 105 suspected angina patients and measured their platelet aggregation using the WBA aggregometer provided by the sponsoring pharmaceutical company. these patient were then given seven 75 mg clopidogrel tablets for one week for a once daily regimen and were asked to come for follow up after one week. Of 133 patients, 105 completed the follow up process and platelet aggregation were measured. Both readings were noted on specially designed farms prepared in accordance with the objective of the study. Patients who were on any other anti-platelet like aspirin warfarine, heparin, etc were excluded from the study.

A total of 105 patients with 28 males (52.83%) and 25 females (47.16%) were included in the study. According to age, the patients were in the range of 35 to 75 years with mean agebeing 55.79+8.74 years. Mean systolic blood pressure was 136.61+18.24 mmHg and mean diastolic blood pressure was 87.80+11.26 mmHg. Standard error of sampling for type A and type B drugs were 0.128 and 0.120, respectively. the platelet aggregation readings after follow up were zero in 73 patients (69.52%), 1-3 ohms in 26 (24.76%), and 4-6 ohms in 6 (5.71%). As a whole, clopidogrel reduced the platelet aggregation readings to below 3 ohms in 99/105 (94.28%), while in 6 (5.71%), there was some expected resistance to clopidogrel, and readings above 3 ohms were recorded. Clopidogrel has a major role in inhibition of platelet aggregation in patients with CAD. But, the activity of clopidogrel and the dose required to inhibit platelet aggregation may depend upon the individuals. Resistance to clopidogrel, especially in low doses, is expected.

Keywords

Peshawar

platelet aggregation

Coronary artery disease

Clopidogrel

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 1 week ago
Scopus by Title: 3
Last Update: 1 week ago
Scopus by Title (Ref): 0
Last Update: 1 week ago
CrossRef: 0
Last Update: 6 days ago

Metrics

Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Hamzullah Khan:[PubMed][Scholar]
Hikmatullah Jan:[PubMed][Scholar]
Mohammad Hafizullah:[PubMed][Scholar]

Outlines

study on clopidogrel in inhibition of platelet aggregation in suspected angina patients, treated with a daily dose of 75 mg of clopidogrel for 7 days

Abstract

Crossmark

Checking

Last Update: 1 week ago

Last Update: 1 week ago

Last Update: 1 week ago

Last Update: 6 days ago